Last reviewed · How we verify

NCT05486533: Acupress

The Effect of Acupressure After Angiography on Pain Level and Hemodynamic Variables

Completed NA Last updated 18 January 2023
What this trial tests

NA trial testing Acupressure in Acupressure in 124 participants. Completed in 30 December 2022.

Timeline
25 November 2022
Primary endpoint
30 December 2022
30 December 2022

Quick facts

Lead sponsorMersin University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment124
Start date25 November 2022
Primary completion30 December 2022
Estimated completion30 December 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mersin University

Who can join

Adults 18 to 80, any sex, with Acupressure or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled study evaluates the effect of acupressure application on the pain level patients after angioography. The hypothesis of this study is that acupressure reduces pain levels and stabilizes hemodynamic variables.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of acupressure on pain level and hemodynamic parameters after coronary angiography: a randomized controlled study.
    Düzel B, Çam Yanik T, Kanat C, Altun Uğraş G. · · 2023 · cited 8× · PMID 37522084 · DOI 10.3389/fcvm.2023.1173363

Verify or expand the search:

Other trials of Acupressure

Trials testing the same drug.

Other recruiting trials for Acupressure

Currently open trials in the same condition.

Other Mersin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05486533.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing